TELA Bio, Inc.
TELA- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001561921
In the last 90 days, TELA Bio, Inc. insiders filed 4 open-market purchases and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $19.3M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in TELA Bio, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −7 vs. Q2 2021
- Shares held
- 10.2M
- +173 (0.0%) vs. Q2 2021
- Total value
- $139.8M
- −$25.1M (−15.2%) vs. Q2 2021
- New holders
- 2
- 15 more added
- Sold out
- 9
- 15 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TELA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $19.3M |
| Q1 2026 | 36 | $16.7M |
| Q4 2025 | 42 | $32.5M |
| Q3 2025 | 40 | $35.1M |
| Q2 2025 | 46 | $45.5M |
| Q1 2025 | 50 | $30.0M |
| Q4 2024 | 47 | $81.6M |
| Q3 2024 | 49 | $45.6M |
| Q2 2024 | 68 | $93.4M |
| Q1 2024 | 59 | $120.6M |
| Q4 2023 | 61 | $142.7M |
| Q3 2023 | 68 | $178.1M |
| Q2 2023 | 68 | $227.2M |
| Q1 2023 | 54 | $180.2M |
| Q4 2022 | 49 | $200.4M |
| Q3 2022 | 45 | $143.0M |
| Q2 2022 | 32 | $95.0M |
| Q1 2022 | 30 | $129.8M |
| Q4 2021 | 36 | $134.8M |
| Q3 2021 | 38 | $139.8M |
| Q2 2021 | 45 | $164.9M |
| Q1 2021 | 47 | $147.4M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding TELA Bio, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 33 | $0 | 0.00% | −6,748−99.5% | Reduced |
| Wells Fargo & Company | 42 | $1.00K | 0.00% | −8−16.0% | Reduced |
| Advisor Group Holdings, Inc. | 200 | $3.00K | 0.00% | 00.0% | Unchanged |
| Meridian Wealth Partners, LLC | 238 | $3.00K | 0.00% | +238 | New |
| Total Clarity Wealth Management, Inc. | 325 | $4.00K | 0.00% | +325 | New |
| Royal Bank of Canada | 1,000 | $14.0K | 0.00% | −210−17.4% | Reduced |
| Bank of America Corp | 2,978 | $41.0K | 0.00% | −4,704−61.2% | Reduced |
| Optiver Holding B.V. | 4,035 | $55.0K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 10,321 | $140.0K | 0.00% | −6,215−37.6% | Reduced |
| UBS Group AG | 13,592 | $186.0K | 0.00% | +236+1.8% | Added |
| Northern Trust Corp | 14,912 | $204.0K | 0.00% | +1,196+8.7% | Added |
| BlackRock Inc. | 21,506 | $294.0K | 0.00% | −384−1.8% | Reduced |
| Ergoteles LLC | 22,297 | $305.0K | 0.01% | +791+3.7% | Added |
| Goldman Sachs Group Inc | 23,220 | $317.0K | 0.00% | −903−3.7% | Reduced |
| State Street Corp | 23,898 | $326.0K | 0.00% | +5,100+27.1% | Added |
| Two Sigma Advisers, LP | 25,794 | $352.0K | 0.00% | −9,206−26.3% | Reduced |
| WMS Partners, LLC | 27,300 | $373.0K | 0.05% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 28,122 | $384.0K | 0.00% | −28,366−50.2% | Reduced |
| Renaissance Technologies LLC | 28,200 | $385.0K | 0.00% | −17,400−38.2% | Reduced |
| The PNC Financial Services Group, Inc. | 47,179 | $644.0K | 0.00% | 00.0% | Unchanged |
| Nomura Holdings Inc | 50,000 | $655.0K | 0.00% | +6,500+14.9% | Added |
| Bridgeway Capital Management, LLC | 62,000 | $847.0K | 0.02% | −25,000−28.7% | Reduced |
| Geode Capital Management, LLC | 64,923 | $886.0K | 0.00% | +824+1.3% | Added |
| Parkman Healthcare Partners LLC | 100,000 | $1.37M | 0.35% | 00.0% | Unchanged |
| Sanders Morris Harris LLC | 107,168 | $1.46M | 0.27% | −13,851−11.4% | Reduced |
| Jacob Asset Management of New York LLC | 113,000 | $1.54M | 0.56% | +10,000+9.7% | Added |
| Schonfeld Strategic Advisors LLC | 144,353 | $1.97M | 0.02% | +7,400+5.4% | Added |
| Granite Point Capital Management, L.P. | 227,644 | $3.11M | 1.21% | +27,644+13.8% | Added |
| Pentwater Capital Management LP | 311,216 | $4.25M | 0.06% | +9,382+3.1% | Added |
| Armistice Capital, LLC | 348,000 | $4.75M | 0.12% | +84,000+31.8% | Added |
| Vanguard Group Inc | 353,969 | $4.84M | 0.00% | +11,689+3.4% | Added |
| Cowen and Company, LLC | 392,100 | $5.36M | 0.26% | +815+0.2% | Added |
| Silvercrest Asset Management Group LLC | 392,975 | $5.37M | 0.04% | −8,991−2.2% | Reduced |
| Opaleye Management Inc. | 443,199 | $6.05M | 1.13% | +2,734+0.6% | Added |
| Pura Vida Investments, LLC | 580,515 | $7.93M | 0.60% | −177,009−23.4% | Reduced |
| RTW Investments, LP | 1,391,619 | $19.0M | 0.29% | −815−0.1% | Reduced |
| Essex Woodlands Management, Inc. | 1,833,989 | $25.1M | 5.56% | +253,900+16.1% | Added |
| OrbiMed Advisors LLC | 3,027,542 | $41.4M | 0.46% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −61,078−100.0% | Sold out |
| Jefferies Group LLC | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| Tibra Equities Europe Ltd | 0 | $0 | 0.00% | −12,900−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −11,747−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,083−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −644−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −278−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |